- Matt has more than 15 years of experience in healthcare investing, most recently managing a $600 mill long/short healthcare portfolio at Catapult/ Millennium prior to joining Foresite Capital.
- Matt also has 17 years of investment banking experience at Kidder Peabody, Smith Barney and Needham, most recently running the healthcare banking effort with a focus on mergers and acquisitions, equity and debt financings and spin-offs.
Prior to joining Foresite Capital, his sector expertise includes: U.S. healthcare services, medical technology, diagnostics, life science tools, big pharmaceutical, and specialty pharmaceuticals.
Matt has more than 15 years of experience in healthcare investing including as an advisor in investment banking, structuring deals for both small and large capitalization companies.
Most recently, he was a healthcare portfolio manager at Catapult/Millennium Partners focused on U.S. healthcare services, medical technology, life science tools, big pharmaceutical, and specialty pharmaceutical. While at Millennium, Matt managed $400-600 million in combined long/short market neutral capital. Prior to joining Millennium, he was co-founder and co-manager of Sapphire Capital, where he focused on medical technology, diagnostics, life science tools suppliers, diagnostic services, and healthcare information technology.
Matt started his career as an investment banking associate focused on mergers and acquisitions, equity and debt financings and spin-offs. He spent time at Smith Barney as a Director in Investment Banking before becoming Managing Director and Head of Healthcare Investment Banking for Needham and Company. While at Needham, he sourced healthcare venture capital opportunities for their venture capital fund, Needham Capital Partners. After that, Matt was an equity analyst for Argus Partners, a $1 billion healthcare fund where he focused on medical technology.